Navigation Links
Neurocrine Biosciences Reports First Quarter 2008 Results
Date:4/30/2008

h endometriosis, utilizing a scale proposed by the FDA. The first Phase II trial will include our selected commercial formulation tablet in two doses, (150 mg and 250 mg); this trial is actively enrolling approximately 150 patients. The Company expects topline results from the first three months of treatment in early 2009. The second trial is a four arm comparator trial of two doses of elagolix, placebo or Leuprolide Depot. This trial is being conducted in Central and Eastern Europe. Topline data from this 3-month double-blind trial of approximately 180 patients should be available in the first half of 2009.

Neurocrine is also investigating the potential of certain GnRH antagonists in treating other hormone-dependent diseases in Men's and Women's Health.

Corticotropin Releasing Factor (CRF1) Receptor Antagonists for Anxiety/Depression and IBS

The CRF collaboration between Neurocrine and GSK has identified multiple unique high affinity and selective antagonists for the CRF1 receptor that are currently in clinical development for mood disorders and irritable bowel syndrome (IBS). There are currently three distinct CRF compounds in clinical development that have arisen out of the GSK collaboration. The first lead compound (876008) is in a Phase II "proof of concept" trial to evaluate its safety and efficacy in patients with IBS. Approximately 130 patients meeting established diagnostic criteria for IBS have been entered into this cross-over design trial. Standard assessments of safety, tolerability and pharmacokinetics will be conducted. The clinical endpoints reflect change in symptom frequency and severity via validated scales for IBS and the data should be available in the second half of 2008.

GSK is also advancing the second lead CRF1 receptor antagonist, 561679, into a Phase II major depression disorder study in the middle of this year.

GSK has also moved a third CRF1 compound, 586529, into a Phase I single dose escalating clinic
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
2. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
3. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
4. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
5. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
6. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
7. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
8. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
9. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
10. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
11. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , July 3, 2015 ... Monitoring & Cardiac Rhythm Management Market ECG, Implantable ... Defibrillator, Implantable Cardioverter Defibrillator, Dual Chamber Pacemaker, CRT-D, ... MarketsandMarkets, the global Cardiac Monitoring (CM) and Cardiac ... reach $26,646.5 Million by 2020 from $21,137.7 Million ...
(Date:7/3/2015)... -- A global continuing medical education provider ... disorders in Latin America through ... to these diseases.      (Logo: http://photos.prnewswire.com/prnh/20150630/227033) , ... Hypertension Online and Manage Thyroid Online ... - combine the world,s top expertise with dynamic learning ...
(Date:7/3/2015)... , July 3, 2015  Obsidian HDS, the ... an online service for the management of data on ... today that PharmaShine now includes the 2014 Open Payments ... Medicare Services on June 30. The data disclosed on ... transactions between industry and providers totaling $6.49 billion and ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Combating Three Major Chronic Diseases in Latin America With Medical Education 2New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2
... Mass. and SYDNEY, Nov. 9, 2010 HeartWare International, ... leading innovator of less invasive, miniaturized circulatory support technologies ... announced today that Keith Aaronson, MD, MS, will present ... November 14, at the American Heart Association (AHA) Scientific ...
... BOTHELL, Wash., Nov. 9, 2010 / PRNewswire-FirstCall/ -- ... ), a global leader in automated external defibrillator ( AED ... results for the third quarter of 2010. The ... million in cardiac monitoring products revenue, $18.1 million in defibrillation ...
Cached Medicine Technology:HeartWare Bridge-to-Transplant Data Featured as Late Breaking Clinical Trial at American Heart Association Scientific Sessions 2010 2Cardiac Science Announces Q3 Results 2Cardiac Science Announces Q3 Results 3Cardiac Science Announces Q3 Results 4Cardiac Science Announces Q3 Results 5Cardiac Science Announces Q3 Results 6Cardiac Science Announces Q3 Results 7Cardiac Science Announces Q3 Results 8Cardiac Science Announces Q3 Results 9Cardiac Science Announces Q3 Results 10Cardiac Science Announces Q3 Results 11Cardiac Science Announces Q3 Results 12
(Date:7/4/2015)... ... , ... Dating a real millionaire online can be more difficult. Millionairematchapp.com ... strives to remove the worries from meeting partners. Recently, the site announced they're ... 2015 and readers have responded with excitement. , “There's quite a few millionaire ...
(Date:7/4/2015)... ... July 04, 2015 , ... ... industry’s leading recognition of technical sales expertise from the North American Board of ... ProfessionalTM. NABCEP is the most highly respected and well established national certification organization ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... 2015 Annual Conference , the premiere continuing education and networking event ... at SeaWorld in Orlando, Florida. Speakers include the leading rheumatology experts in ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. Smith, the ... to lead a national chief nursing officer recruitment for Jane Phillips ... the healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare ...
(Date:7/3/2015)... ... ... Jennifer Renee Hanes, DO is the new Medical Director of its Sienna Plantation ... emergency rooms in the United States. , “We are excited to welcome Dr. Hanes ... Director of First Choice Emergency Room, Dr. James M. Muzzarelli. , Dr. Hanes ...
Breaking Medicine News(10 mins):Health News:MillionaireMatchapp.com Publishes the Best Millionaire Dating App and Official Dating Site Reviews 2015 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3
... By Steven Reinberg HealthDay Reporter , MONDAY, ... injuries from playing interactive video games such as Nintendo Wii ... children who are bystanders sometimes getting hurt. However, one ... interactive video game, or of being injured while watching someone ...
... William R. Jacobs, Jr., Ph.D. , professor of microbiology & ... College of Medicine of Yeshiva University, who is also a ... a three-year, $4 million grant from the National Institutes of ... tuberculosis (TB). TB causes almost two million deaths each year ...
... C. Wittig, M.D. and colleagues will conduct a total ... Clinical Congress of the American College of Surgeons and ... Surgery of the Hand. Dr. Wittig, an orthopedic ... Chief of the Division of Skin and Sarcoma Cancer ...
... 36 per cent more questions about the procedure correctly ... than just talking to medical staff, according to research ... BJUI . Researchers from the University of Melbourne, ... into two groups. The first group went through the ...
... metabolises drugs save both time and money, the ... combining such simulations with,laboratory experiments, reveals a researcher ... demonstrates the benefits of combining traditional laboratory experiments ... how the body,s various enzymes interact with a ...
... SAN FRANCISCO New mothers who smoke are less likely ... prior to becoming pregnant were significantly more likely to remain ... encouragement during the first eight weeks following child birth, according ... Academy of Pediatrics (AAP) National Conference and Exhibition in San ...
Cached Medicine News:Health News: Interactive Video Games Linked to Injuries 2Health News:Einstein scientist awarded $4 million to develop genetic strategy to combat tuberculosis 2Health News:John Theurer Cancer Center to present innovative research at 2 surgical meetings 2Health News:John Theurer Cancer Center to present innovative research at 2 surgical meetings 3Health News:John Theurer Cancer Center to present innovative research at 2 surgical meetings 4Health News:John Theurer Cancer Center to present innovative research at 2 surgical meetings 5Health News:Interactive media improved patients’ understanding of cancer surgery by more than a third 2Health News:Best drug development results from computer/test tube combination 2Health News:Postpartum intervention/support prevents smoking relapse, extends breastfeeding duration 2